Lv11
58 积分 2024-12-02 加入
Global cancer statistics 2024: GLOBOCAN estimates of incidence and mortality worldwide for 34 cancers in 186 countries
48分钟前
已完结
Cancer burden and control in China: landscape, trends and challenges
58分钟前
已完结
Clinical and biomarker analyses of SHR-1701 combined with famitinib in patients with previously treated advanced biliary tract cancer or pancreatic ductal adenocarcinoma: a phase II trial
7个月前
已完结
Concordance of Circulating Tumor DNA, Primary and Metastatic Tissue DNA, and Immunohistochemistry in Gastroesophageal Carcinoma
7个月前
已关闭
AFP (alpha fetoprotein): Who are you in gastrology?
8个月前
已完结
Event-free survival by residual cancer burden with pembrolizumab in early-stage TNBC: exploratory analysis from KEYNOTE-522
8个月前
已完结
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
9个月前
已完结
Recent advances in natural polysaccharides against hepatocellular carcinoma: A review
9个月前
已完结
The combination of circulating IgM and geriatric nutritional risk index predicts the prognostic of hepatocellular carcinoma patients who underwent immune checkpoint inhibitors
9个月前
已完结
Safety, Efficacy, and Pharmacokinetics of SHR-A1811, a Human Epidermal Growth Factor Receptor 2–Directed Antibody-Drug Conjugate, in Human Epidermal Growth Factor Receptor 2–Expressing or Mutated Advanced Solid Tumors: A Global Phase I Trial
10个月前
已完结
皖公网安备34019202002308
